Advance in Gluten-Free Diet
The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes,...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (110 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545643704498 |
---|---|
ctrlnum |
(CKB)5400000000040514 (oapen)https://directory.doabooks.org/handle/20.500.12854/68320 (EXLCZ)995400000000040514 |
collection |
bib_alma |
record_format |
marc |
spelling |
Paolo, Usai-Satta edt Advance in Gluten-Free Diet Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (110 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers. English Research & information: general bicssc Biology, life sciences bicssc Food & society bicssc irritable bowel syndrome celiac disease nonceliac gluten/wheat sensitivity gluten-free diet AIDAI score amylase trypsin inhibitor non-celiac wheat sensitivity CD14 lymphocytes interleukin-1beta tumor necrosis factor-α non coeliac wheat sensitivity gluten FODMAPs functional dyspepsia Celiac disease iron deficiency without anemia dietary iron iron supplementation women refractory celiac disease remission nickel allergy allergic contact mucositis irritable bowel syndrome (IBS) low-nickel diet gluten-free products gluten containing products food composition database dietary reference intake prison diets irritable bowel disease FODMAP low FODMAP diet gluten free diet non-celiac gluten wheat sensitivity 3-03943-871-9 3-03943-872-7 Paolo, Usai-Satta oth |
language |
English |
format |
eBook |
author2 |
Paolo, Usai-Satta |
author_facet |
Paolo, Usai-Satta |
author2_variant |
u s p usp |
author2_role |
Sonstige |
title |
Advance in Gluten-Free Diet |
spellingShingle |
Advance in Gluten-Free Diet |
title_full |
Advance in Gluten-Free Diet |
title_fullStr |
Advance in Gluten-Free Diet |
title_full_unstemmed |
Advance in Gluten-Free Diet |
title_auth |
Advance in Gluten-Free Diet |
title_new |
Advance in Gluten-Free Diet |
title_sort |
advance in gluten-free diet |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2021 |
physical |
1 electronic resource (110 p.) |
isbn |
3-03943-871-9 3-03943-872-7 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT paolousaisatta advanceinglutenfreediet |
status_str |
n |
ids_txt_mv |
(CKB)5400000000040514 (oapen)https://directory.doabooks.org/handle/20.500.12854/68320 (EXLCZ)995400000000040514 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Advance in Gluten-Free Diet |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548867320872962 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03455nam-a2200745z--4500</leader><controlfield tag="001">993545643704498</controlfield><controlfield tag="005">20231214133057.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040514</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68320</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040514</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Paolo, Usai-Satta</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advance in Gluten-Free Diet</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (110 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Food & society</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">irritable bowel syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">celiac disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nonceliac gluten/wheat sensitivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gluten-free diet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AIDAI score</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amylase trypsin inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-celiac wheat sensitivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD14 lymphocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin-1beta</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor necrosis factor-α</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non coeliac wheat sensitivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gluten</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FODMAPs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">functional dyspepsia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Celiac disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iron deficiency without anemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dietary iron</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iron supplementation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">women</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">refractory celiac disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">remission</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nickel allergy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">allergic contact mucositis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">irritable bowel syndrome (IBS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low-nickel diet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gluten-free products</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gluten containing products</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">food composition database</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dietary reference intake</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prison diets</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">irritable bowel disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FODMAP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low FODMAP diet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gluten free diet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-celiac gluten wheat sensitivity</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-871-9</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-872-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paolo, Usai-Satta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:42:09 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338005670004498&Force_direct=true</subfield><subfield code="Z">5338005670004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338005670004498</subfield></datafield></record></collection> |